Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
CI Global Healthcare Leaders Index ETF Unhedged Common Units (CHCL.B : NEO)
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade B
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade A
Click for more information on Fundata’s ESG Grade.
|
Close (07-23-2026) |
$25.65 |
|---|---|
| Change |
$0.24
(0.94%)
|
| Open | $25.70 |
|---|---|
| Day Range | $25.70 - $25.70 |
| Volume | 2,000 |
As at June 30, 2026
As at June 30, 2026
As at June 30, 2026
Loading......
Loading......
Legend
Compare Options
Fund Returns
Inception Return (August 12, 2021): 6.66%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 8.30% | 8.98% | 6.04% | 6.04% | 22.03% | 6.94% | 9.37% | 9.37% | - | - | - | - | - | - |
| Benchmark | 7.68% | 8.56% | 5.60% | 5.60% | 20.56% | 7.33% | 9.46% | 9.21% | 6.48% | 7.57% | 9.16% | 9.16% | 9.22% | 9.36% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 22 / 55 | 27 / 55 | 15 / 53 | 15 / 53 | 20 / 53 | 16 / 52 | 15 / 50 | 9 / 43 | - | - | - | - | - | - |
| Quartile Ranking | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | - | - | - | - | - | - |
Monthly Return
| Return % | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -1.72% | 4.32% | 2.56% | 4.08% | 7.85% | -2.51% | -0.04% | 3.70% | -6.12% | -2.53% | 3.24% | 8.30% |
| Benchmark | -0.60% | 4.16% | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% | 3.08% | 7.68% |
Best Monthly Return Since Inception
8.30% (June 2026)
Worst Monthly Return Since Inception
-6.84% (January 2022)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | 1.35% | 0.56% | 10.18% | 9.58% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | - | 1 | 3 | 2 | 2 |
| Category Rank | - | - | - | - | - | - | 9/ 42 | 23/ 43 | 15/ 50 | 23/ 52 |
Best Calendar Return (Last 10 years)
10.18% (2024)
Worst Calendar Return (Last 10 years)
0.56% (2023)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 71.68 |
| International Equity | 28.21 |
| Cash and Equivalents | 0.12 |
| Other | -0.01 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 95.96 |
| Consumer Services | 1.90 |
| Consumer Goods | 1.35 |
| Industrial Goods | 0.37 |
| Cash and Cash Equivalent | 0.12 |
| Other | 0.30 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 71.78 |
| Europe | 22.99 |
| Asia | 4.45 |
| Africa and Middle East | 0.45 |
| Latin America | 0.19 |
| Other | 0.14 |
Top Holdings
| Name | Percent |
|---|---|
| Eli Lilly and Co | 11.88 |
| Johnson & Johnson | 7.17 |
| Abbvie Inc | 5.22 |
| UnitedHealth Group Inc | 4.42 |
| Merck & Co Inc | 3.74 |
| Roche Holding AG | 3.54 |
| Novartis AG Cl N | 3.33 |
| AstraZeneca PLC | 3.29 |
| Amgen Inc | 2.28 |
| Thermo Fisher Scientific Inc | 2.18 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
CI Global Healthcare Leaders Index ETF Unhedged Common Units
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 12.61% | - | - |
|---|---|---|---|
| Beta | 1.05% | - | - |
| Alpha | -0.01% | - | - |
| Rsquared | 0.99% | - | - |
| Sharpe | 0.49% | - | - |
| Sortino | 0.88% | - | - |
| Treynor | 0.06% | - | - |
| Tax Efficiency | 94.50% | - | - |
| Volatility |
|
- | - |
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 15.23% | 12.61% | - | - |
| Beta | 1.06% | 1.05% | - | - |
| Alpha | 0.00% | -0.01% | - | - |
| Rsquared | 0.99% | 0.99% | - | - |
| Sharpe | 1.23% | 0.49% | - | - |
| Sortino | 2.34% | 0.88% | - | - |
| Treynor | 0.18% | 0.06% | - | - |
| Tax Efficiency | 97.66% | 94.50% | - | - |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | August 12, 2021 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | $97 |
| 52 Week High | $26.65 |
| 52 Week Low | $20.56 |
| Annual Dividend | $0.28 |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
ETF Characteristics
| Exposure | - |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
Investment Objectives
CHCL seeks to replicate, to the extent reasonably possible, the performance of a global healthcare index, net of expenses. Currently, CHCL seeks to replicate the performance of the Solactive Developed Markets Healthcare 150 CAD Index (CA NTR) (the “Index”). The Index intends to track the performance of the largest 150 companies from the global healthcare industry.
Investment Strategy
The investment strategy of each Index ETF is to invest in and hold, to the extent reasonably possible, the Constituent Securities of the applicable Index in substantially the same proportion as they are reflected in the applicable Index.
Portfolio Management
| Portfolio Manager |
CI Global Asset Management |
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
CI Global Asset Management |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
Fees
| MER | 0.37% |
|---|---|
| Management Fee | 0.35% |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
